Literature DB >> 1375991

Mechanism of acetylcholine action on pacemaker current (i(f)) in canine Purkinje fibers.

F Chang1, I S Cohen.   

Abstract

We have recently reported in canine Purkinje fibers that acetylcholine (ACh) can reverse the positive voltage shift of the pacemaker current (i(f)) induced by beta-adrenergic stimulation while having no direct action of its own. We have now investigated this effect of ACh on the cyclic adenosine monophosphate (cAMP) cascade in more detail. We find that addition of a membrane permeable analogue of cAMP (8-chlorophenylthio cAMP), 0.5-1 mM, increased the amplitude of i(f). This action was not reversed by 1 microM ACh, implying that ACh acts at a step prior to cAMP action. We then looked at the steps controlling intracellular concentration of cAMP. Inhibiting the phosphodiesterase with 100 microM isobutyl-1-methylxanthine (IBMX) increased i(f). This action, however, was reversed by ACh. Finally we investigated whether the action of forskolin, a direct activator of adenylyl cyclase, could be reversed by ACh. Forskolin (10-20 microM) increased i(f), and ACh at 1 microM partially reversed this action of forskolin. These results suggest that, in canine Purkinje fibers, ACh reverses the positive action of beta-adrenergic agents on i(f) via a decrease in cAMP production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1375991     DOI: 10.1007/bf00374474

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  22 in total

1.  Heart rate regulation by G proteins acting on the cardiac pacemaker channel.

Authors:  A Yatani; K Okabe; J Codina; L Birnbaumer; A M Brown
Journal:  Science       Date:  1990-09-07       Impact factor: 47.728

2.  Properties of the hyperpolarizing-activated current (if) in cells isolated from the rabbit sino-atrial node.

Authors:  D DiFrancesco; A Ferroni; M Mazzanti; C Tromba
Journal:  J Physiol       Date:  1986-08       Impact factor: 5.182

Review 3.  A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.

Authors:  R E Weishaar; M H Cain; J A Bristol
Journal:  J Med Chem       Date:  1985-05       Impact factor: 7.446

4.  Muscarinic modulation of cardiac rate at low acetylcholine concentrations.

Authors:  D DiFrancesco; P Ducouret; R B Robinson
Journal:  Science       Date:  1989-02-03       Impact factor: 47.728

5.  Changes by acetylcholine of membrane currents in rabbit cardiac Purkinje fibres.

Authors:  E Carmeliet; K Mubagwa
Journal:  J Physiol       Date:  1986-02       Impact factor: 5.182

6.  Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells.

Authors:  H C Hartzell; R Fischmeister
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

7.  Muscarinic control of the hyperpolarization-activated current (if) in rabbit sino-atrial node myocytes.

Authors:  D DiFrancesco; C Tromba
Journal:  J Physiol       Date:  1988-11       Impact factor: 5.182

8.  A new interpretation of the pace-maker current in calf Purkinje fibres.

Authors:  D DiFrancesco
Journal:  J Physiol       Date:  1981-05       Impact factor: 5.182

9.  Inhibition of the hyperpolarization-activated current (if) induced by acetylcholine in rabbit sino-atrial node myocytes.

Authors:  D DiFrancesco; C Tromba
Journal:  J Physiol       Date:  1988-11       Impact factor: 5.182

10.  Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein.

Authors:  K Seamon; J W Daly
Journal:  J Biol Chem       Date:  1981-10-10       Impact factor: 5.157

View more
  2 in total

1.  Pacemaker current i(f) in adult canine cardiac ventricular myocytes.

Authors:  H Yu; F Chang; I S Cohen
Journal:  J Physiol       Date:  1995-06-01       Impact factor: 5.182

2.  Modulation of the hyperpolarization-activated current (Ih) by cyclic nucleotides in guinea-pig primary afferent neurons.

Authors:  S L Ingram; J T Williams
Journal:  J Physiol       Date:  1996-04-01       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.